Prohemostatic treatment in cardiac surgery

Area of Science:

• Cardiovascular Medicine
• Hematology

Background:

• Cardiac surgery patients present complex coagulopathy beyond blood loss.
• Factors include hemodilution, inflammation, and cardiopulmonary bypass-induced hemostatic activation.
• These factors offer therapeutic intervention targets.

Purpose of the Study:

• To review pharmacological agents for managing coagulopathy in cardiac surgery.
• To discuss strategies for reducing allogeneic blood transfusions.

Main Methods:

• Literature review of pharmacological agents used in cardiac surgery.
• Discussion of antifibrinolytics, prohemostatic agents, and topical agents.

Main Results:

• Multiple agents exist to manage bleeding and coagulation.
• Preemptive and prohemostatic strategies are employed.

Conclusions:

• Pharmacological interventions are crucial for managing coagulopathy in cardiac surgery.
• Targeting specific hemostatic pathways can reduce transfusion needs.